rethinkPeptides Search
Menu
Home / Research library
Study breakdown

Tirzepatide achieves dose-dependent weight loss of 5-22.7% in comprehensive meta-analysis of obesity and T2DM trials

RPEP-138052025Tian, Qiru; Song, Yi; Deng, Yan; Lin, Shike
evidence
The takeaway

Meta-analysis of phase 1-3 trials confirms tirzepatide's dose-dependent weight loss: 5 mg produces ~5%, 10 mg ~11-15%, and 15 mg ~15-22.7% weight reduction, with consistent efficacy in both obesity and T2DM populations.

Up to 22.7% weight loss at 15 mg

Tirzepatide's dose-response is clear and consistent: triple the dose approximately triples the weight loss from 5% to 22.7%

What the researchers found

Dose-response: 5 mg ~5%; 10 mg ~11-15%; 15 mg ~15-22.7% weight loss. Consistent in obesity + T2DM. Phase 1-3 trials included. GI AEs main side effects. Dose-dependent tolerability profile.

Why it matters

Quantifying the exact dose-response relationship helps clinicians and patients set realistic expectations and choose the right dose based on weight loss goals and side effect tolerance.

How the study worked

Systematic review and meta-analysis of phase 1-3 tirzepatide trials. Dose-response analysis (5, 10, 15 mg). Weight loss and adverse event assessment.

What this study cannot tell us

Meta-analysis of published trials. Individual patient data not available. Dose titration schedules varied. Long-term weight maintenance not assessed.

How to read the evidence

Meta-analysis of phase 1-3 RCTs. High-quality dose-response evidence.

When this study was published

Published in 2025.

The bigger picture

Having precise dose-response data enables personalized dosing—starting lower for tolerability-focused patients and escalating for those seeking maximum weight loss.

Questions still open

  • Is the 15 mg dose tolerable enough for most patients?
  • Would intermediate doses (7.5 mg, 12.5 mg) improve the benefit-risk ratio?
  • Does the dose-response plateau beyond 15 mg?

Common questions

How much weight will I lose on tirzepatide?
It depends on the dose: the 5 mg dose produces about 5% weight loss, 10 mg about 11-15%, and the maximum 15 mg dose achieves 15-22.7%. Your doctor will typically start at the lowest dose and increase gradually based on your response and tolerance of side effects.
Should I take the highest dose of tirzepatide?
Not necessarily. While the 15 mg dose produces the most weight loss, it also has more GI side effects. Some patients achieve excellent results at 10 mg with better tolerability. Your doctor can help find the right balance between weight loss goals and side effect comfort.

Read the original research

Efficacy and safety of tirzepatide for weight loss in patients with obesity or type 2 diabetes: a systematic review and meta-analysis.

Frontiers in endocrinology, 16, 1593134

View on PubMed ↗Publisher’s paper ↗

Citation

Tian, Qiru; Song, Yi; Deng, Yan; Lin, Shike. (2025). Efficacy and safety of tirzepatide for weight loss in patients with obesity or type 2 diabetes: a systematic review and meta-analysis.. Frontiers in endocrinology, 16, 1593134. https://doi.org/10.3389/fendo.2025.1593134